Company intelligence / Profile preview

Nyra Medical

Atlanta, Georgia, United Statesnyramed.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Nyra Medical has developed the CARLEN system, a sutureless, single-leaflet transcatheter device designed to augment native mitral valve anatomy for patients with functional mitral regurgitation. The company completed over 70 nonclinical implants before launching First-in-Human studies outside the US in 2025. Clinical results are pending as trials are ongoing.

Therapeutic areas: Cardiovascular
Modalities: Device (Transcatheter mitral valve repair device)
Industry: Surgical Medical Devices

Partnerships

Vensana Capital and a large unnamed global medical device company have invested; no disclosed commercial partnerships yet.

Beyond the preview

Go deeper on Nyra Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nyra Medical.

Explore the full profile